1-19656983-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005380.8(NBL1):āc.400G>Cā(p.Val134Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,455,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005380.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NBL1 | NM_005380.8 | c.400G>C | p.Val134Leu | missense_variant | 4/4 | ENST00000375136.8 | |
MICOS10-NBL1 | NM_001204088.2 | c.442G>C | p.Val148Leu | missense_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NBL1 | ENST00000375136.8 | c.400G>C | p.Val134Leu | missense_variant | 4/4 | 1 | NM_005380.8 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152124Hom.: 0 Cov.: 31 FAILED QC
GnomAD3 exomes AF: 0.00000859 AC: 2AN: 232730Hom.: 0 AF XY: 0.00000791 AC XY: 1AN XY: 126478
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1455924Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 723798
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 152124Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.442G>C (p.V148L) alteration is located in exon 5 (coding exon 4) of the MINOS1-NBL1 gene. This alteration results from a G to C substitution at nucleotide position 442, causing the valine (V) at amino acid position 148 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at